ELMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30

Electromed, Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 25, 2026

$27.40−0.02 (-0.07%)

Close on Oct 19, 2026

Market cap: $239.32M
P/E (TTM): 21.1
Dividend yield: –

Dividends

Electromed has not reported a dividend

No dividend per share appears in Electromed's annual filings since fiscal 2011.

Where these numbers come from

Parsed from the XBRL in Electromed's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ELMD.

Revenue growth15.3% · median 16.9%

Gross margin78.5% · median 77.1%

Operating margin18.8% · median -45.3%

Net margin15.3% · median -47.5%

Company	Revenue	Growth
BLFS	$102.82M	+25.4%
LUNG	$87.44M	-3.4%
ELMD	$73.78M	+15.3%
ECOR	$36.97M	+33.5%
NUWE	$9.01M	+8.4%
FOCL	–	–

Company

Next earnings (est.): Nov 11, 2026, during market hours
Exchange: NYSE
Industry: Electromedical & Electrotherapeutic Apparatus
Fiscal year ends: June 30
Employees: 197
Held by institutions: 55.6%
Auditor: RSM US LLP
SEC CIK: 1488917

Advertisement
300 × 250